BDCDA seeks reconsideration of Karnataka Drugs & Cosmetics Rules Amendments: Nandita Vijayasimha, Bengaluru Saturday, January ...

Gireesh Babu, New Delhi Saturday, January 10, 2026, 08:00 Hrs [IST] ...

Pronto Consult observes India’s 2025 healthcare shift from reactive protection to aspirational prevention: Peethaambaran Kunnathoor, Chennai Saturday, January 10, 2026, 08:00 Hr ...

Panel asks Ayush Ministry to intensify efforts to clear pending Utilisation Certificates: Gireesh Babu, New Delhi Saturday, January 10, 2026, 08:00 Hrs [IST] Raising concerns over ...

Experts recommend eliminating inverted duty structure, incentives for research in Union Budget 2026: Shardul Nautiyal, Mumbai Saturday, January 10, 2026, 08:00 Hrs [IST] Experts h ...

Allschwil, Switzerland Friday, January 9, 2026, 13:00 Hrs [IST] ...

Merck begins phase 3 KANDLELIT-007 trial of calderasib in combo Keytruda QLEX in certain patients with advanced NSCLC: Rahway, New Jersey Friday, January 9, 2026, 15:00 Hrs [IST] ...

Ascentage Pharma receives US FDA’s IND clearance for BTK degrader APG-3288 to treat patients with relapsed/refractory B-cell malignancies: Rockville, Maryland Friday, January 9, ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has on 7th January, 2026 approved the medicine Nirogacestat hydrobromide (Ogsiveo) for the treatment of progressing desmoid tumours in ...

Shilpa Medicare targets US approval of 5-HT3 receptor antiemetic for chemotherapy-induced nausea and vomiting: Our Bureau, Bengaluru Friday, January 9, 2026, 12:15 Hrs [IST] Shilp ...

Inizio Ignite sparks a new era of connected advisory solutions to accelerate pharmaceutical performance: Chicago Friday, January 9, 2026, 18:00 Hrs [IST] Inizio, a leading global ...

Sobi to advance Gamifant in interferon-gamma-driven sepsis based on EMBRACE topline data: Stockholm Friday, January 9, 2026, 11:00 Hrs [IST] Sobi, a global biopharma company, anno ...